Influenza
Showing NaN - NaN of 74
SARS-CoV-2, Influenza Trial in Canada, United States (mRNA-1083, Placebo, Influenza Vaccine)
Not yet recruiting
- SARS-CoV-2
- Influenza
- mRNA-1083
- +3 more
-
Anniston, Alabama
- +172 more
Oct 18, 2023
SARS-CoV-2, Influenza Trial in United States (Fluarix, mRNA-1083.1, mRNA-1083.2)
Recruiting
- SARS-CoV-2
- Influenza
- Fluarix
- +8 more
-
Chandler, Arizona
- +68 more
Apr 24, 2023
Influenza Trial in Worldwide (Baloxavir Marboxil, Placebo)
Recruiting
- Influenza
- Baloxavir Marboxil
- Placebo
-
Birmingham, Alabama
- +290 more
Jan 20, 2023
SARS-CoV-2, Influenza Trial in United States (mRNA-1073, mRNA-1010, mRNA-1273)
Active, not recruiting
- SARS-CoV-2
- Influenza
- mRNA-1073
- +3 more
-
Hollywood, Florida
- +13 more
Oct 5, 2022
Defining Impact of Initial Influenza Exposure on Immunity in
Recruiting
- Influenza
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Jun 23, 2022
Influenza, Human Trial in United States (Investigational aIIV4c, IIV4c type 1, aIIV4)
Completed
- Influenza
- Human
- Investigational aIIV4c
- +3 more
-
Mobile, Alabama
- +20 more
Mar 15, 2022
Influenza, Influenza Immunisation Trial in United States (AF03, Delta Inulin-CpG55.2, Influenza Virus Quadrivalent Inactivated
Influenza Trial in Worldwide (Liquid CAIV-T)
Completed
- Influenza
- Liquid CAIV-T
-
Hoover, Alabama
- +160 more
Sep 10, 2021
Influenza Trial in United States (Influenza A/Bethesda/MM2/H1N1 Challenge)
Completed
- Influenza
- Influenza A/Bethesda/MM2/H1N1 Challenge
-
Baltimore, Maryland
- +3 more
Apr 1, 2021
Asthma in Children, Vaccine Adverse Reaction, Vaccine Reaction Trial in Durham, Cincinnati, Nashville (Live Attenuated Influenza
Completed
- Asthma in Children
- +5 more
- Live Attenuated Influenza Vaccine (LAIV)
- Inactivated Influenza Vaccine (IIV)
-
Durham, North Carolina
- +2 more
Feb 25, 2021
Influenza, Vaccine Trial in Durham, Cincinnati (cH8/1N1 LAIV, AS03-adjuvanted cH5/1N1 IIV, cH5/1N1 IIV)
Completed
- Influenza
- Vaccine
- cH8/1N1 LAIV
- +5 more
-
Durham, North Carolina
- +1 more
Feb 1, 2021
Influenza, Influenza Immunisation Trial in Iowa City, Cincinnati, Houston (Influenza Multimeric-001 Vaccine, Placebo,
Completed
- Influenza
- Influenza Immunisation
- Influenza Multimeric-001 Vaccine
- +2 more
-
Iowa City, Iowa
- +2 more
Jun 2, 2020
Influenza Trial in United States (Seasonal Influenza DNA vaccine, TIV)
Completed
- Influenza
- Seasonal Influenza DNA vaccine
- TIV
-
Atlanta, Georgia
- +4 more
Dec 4, 2018
Influenza Trial in Worldwide (40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate, Placebo)
Completed
- Influenza
- 40 mg Laninamivir Octanoate
- +2 more
-
Scottsboro, Alabama
- +220 more
May 29, 2018
Influenza Trial in United States (CSL Limited Influenza Virus Vaccine (Afluria®), US Licensed Influenza Virus Vaccine
Completed
- Influenza
- CSL Limited Influenza Virus Vaccine (Afluria®)
- US Licensed Influenza Virus Vaccine (Fluzone®)
-
Mountain Home, Arkansas
- +12 more
Apr 25, 2018
Influenza Trial in United States (CSL's 2009 H1N1 Influenza Vaccine (CSL425), Placebo)
Completed
- Influenza
- CSL's 2009 H1N1 Influenza Vaccine (CSL425)
- Placebo
-
Chandler, Arizona
- +12 more
Apr 25, 2018
Influenza Trial in United States (Influenza Virus Vaccine, Monovalent A/H3N2v A/Minnesota/11/2010 NYMC X-203)
Completed
- Influenza
- Influenza Virus Vaccine, Monovalent A/H3N2v A/Minnesota/11/2010 NYMC X-203
-
Atlanta, Georgia
- +7 more
Jul 3, 2017
Influenza Trial in United States (CSL's Influenza Virus Vaccine (Afluria), Influenza Virus Vaccine (Fluzone))
Completed
- Influenza
- CSL's Influenza Virus Vaccine (Afluria)
- Influenza Virus Vaccine (Fluzone)
-
Chandler, Arizona
- +22 more
Apr 16, 2017
Influenza Trial in Worldwide (Fluarix, adjuvanted influenza vaccine)
Completed
- Influenza
- Fluarix
- adjuvanted influenza vaccine
-
Clearwater, Florida
- +29 more
Apr 20, 2017
Influenza Trial in United States (Influenza)
Completed
- Influenza
- Influenza
-
Clearwater, Florida
- +14 more
Jan 16, 2017